Antibody Therapeutics: A Guide To What’s New And Next

Add Bookmark

  • NEWSLETTERS

Stay Connected Newsletter, Pharmaceuticals

End-to-End Workflows

USP-Compliant Analysis Of Antibody Drugs Using Size-Exclusion Chromatography (SEC) | Shimadzu

Effective mAb Characterization:
USP-Compliant Size Variant Analysis

Automated Method Development For Antibody-Drug Conjugates (ADC) Charge Variants Analysis

Automated Method Development:
Simplifying ADC Charge Variant Analysis

Fully Automated Sample Preparation For Profiling Antibody N-Linked Glycans | Shimadzu

Effortless Sample Preparation:
Antibody N-Linked Glycan Profiling

Spotlight

Nexera XS inert

Nexera XS Inert

Discover the Nexera XS inert UHPLC system, designed to elevate biopharmaceutical analysis. Combining 105 MPa pressure capacity with bioinert materials, it minimizes metal adsorption for sharper peaks and greater accuracy. Resistant to corrosion and extreme pH levels,  it’s built to handle complex samples with exceptional reliability and precision.

 

Learn More 

Learning Resources

Digital Classroom 

 

Latest Biopharma Innovation:
Autonomous, Scalable & Cost-Effective Solutions For Downstream Processing

Streamlining Chromatography: Faster, More Reliable Method Development with AQbD

 

Advancing Separation Science:
SFE/SFC For Chiral & Achiral Analysis

 

Subscribe to Shimadzu's Newsletter Today!